Death Threats and Abuse: Doctors Brave the ‘Abortion Desert’
To safeguard their patients’ reproductive rights, physicians risk personal safety to fly to places where abortion access is severely limited. Medscape Medical News …read more
To safeguard their patients’ reproductive rights, physicians risk personal safety to fly to places where abortion access is severely limited. Medscape Medical News …read more
The FDA has allowed marketing of the first rapid diagnostic test (RDT) to identify Ebola virus antigens, or proteins, in certain body fluids from living and deceased individuals. FDA Approvals …read more
Women on dialysis are more likely to become pregnant than previously thought, but the rate of live births is low compared with the general population. Preconception counseling is advised. Medscape Medical News …read more
There are many possible causes of pain in the perineum, which can be uncomfortable and disruptive. Here, we discuss possible causes and treatments that can help. …read more
Earlier this year, a hospice nurse was diagnosed with early-stage breast cancer and took time off for treatment. Three months later, the hospice fired the nurse, saying she could be rehired ‘if and when’ she gets better. Medscape Medical News …read more
Study suggests a “window of opportunity” in the first few years after diagnosis of type 2 diabetes during which modest weight loss, without need for extreme calorie restriction, can lead to remission. Medscape Medical News …read more
Older patients who suffer a hip or vertebral fracture are failing to begin treatment for osteoporosis to prevent a secondary break. The reasons are multiple; new guidance seeks to address the issues. Medscape Medical News …read more
Dr Andrew Kaunitz recommends keeping our eyes on the ‘big picture’ in decisions about the use of menopausal hormone therapy. Medscape Ob/Gyn …read more
Post-hoc analysis of the FRAME study indicates that romosozumab is effective for osteoporosis, and safe, across most stages of renal disease. Medscape Medical News …read more
A European Medicines Agency committee warns against using certain estradiol creams for longer than a single period of 4 weeks to reduce the risk for adverse health effects. International Approvals …read more